CALAMOS NASDAQ-100 STRUCTURED ALT PROTECTION ETF - SEPTEMBER

26.24

0.0000

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:26.24

Open:26.24

Low:26.24

Close:26.24

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure

GlobeNewswire

·

23 Apr

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CPNS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CPNS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPNS\",,,,,undefined,":{"symbol":"CPNS","market":"US","secType":"STK","nameCN":"CALAMOS NASDAQ-100 STRUCTURED ALT PROTECTION ETF - SEPTEMBER","latestPrice":26.2414,"timestamp":1751311076936,"preClose":26.2414,"halted":0,"volume":0,"delay":0,"floatShares":900001,"shares":0,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"06-30 15:17:56 EDT","open":26.2414,"high":26.2414,"low":26.2414,"amount":0,"amplitude":0,"askPrice":26.35,"askSize":200,"bidPrice":26.31,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1751313600000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":26.2414,"sharesOutstanding":900001,"nav":26.311076,"aum":23679994.64,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPNS\",,,,,undefined,":{"symbol":"CPNS","floatShares":900001,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":26.2414,"amplitude":0,"preClose":26.2414,"low":26.2414,"week52Low":24.62,"pbRate":"--","week52High":27.18,"institutionHeld":0,"latestPrice":26.2414,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":26.2414,"prevYearClose":25.38,"prevWeekClose":26.2414,"prevMonthClose":25.9488,"prevQuarterClose":25.3393,"fiveDayClose":26.0941,"twentyDayClose":25.9488,"sixtyDayClose":25.226},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CPNS\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CPNS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529138507","title":"Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2529138507","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529138507?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:00","pubTimestamp":1745409600,"startTime":"0","endTime":"0","summary":"Initial Clinical Studies Completed with Significant Positive Results. The Cleveland Clinic Foundation, Abbott Laboratories and a New Era Associates  fund to Acquire Economic Interests in VTAK. Cardionomic was a venture capital and strategic investor-funded privately held company backed by the Cleveland Clinic Foundation, Abbott Laboratories and New Enterprise Associates  that had been developing for a number of years a new therapy based upon novel technology for the treatment of acute decompensated heart failure, or ADHF, for which over 1 million Americans are hospitalized annually. Patients admitted for ADHF have high in-hospital morbidity, frequent rehospitalization and subsequent death. The CPNS System consists of electrical stimulation via a temporary catheter inserted in the pulmonary artery targeting the root cause of heart failure by stimulating the autonomic cardiac nerves to restore autonomic balance. The initial target patient population for the therapy is hospitalized ADHF p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/catheter-precision-acquire-assets-development-120000911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1914381329.SGD","LU2237957902.USD","LU0868494617.USD","BK4568","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1721429402.USD","SSI","IE00B2B36J28.USD","BK4588","LU1989763427.SGD","SG9999004303.SGD","LU0266013472.USD","CPNS","LU2133065610.SGD","LU2468319806.SGD","LU0170899867.USD","LU0122379950.USD","BK4585","LU1989763690.USD","LU1057294990.SGD","SG9999002232.USD","LU1023059063.AUD","VTAK","BK4581","BK4533","LU2237957811.SGD","LU1721429741.USD","BK4504","LU2112291526.USD","SG9999002224.SGD","BK4082","BK4566","ABT","IE00BFTCPJ56.SGD","LU0234572021.USD","LU1691799644.USD","NEA","LU1061106388.HKD","SGXZ23171101.USD","BK4592"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CPNS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CPNS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CPNS\",market:\"US\",delay:false,,,undefined,":{}}}